ArticleCancers2021

Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience.

Lavinia Monaco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.